Information:
Error:
ID
12357
Description
Study description: Study documentation part- Study termination. This is a phase II multicenter trial with Rivaroxaban in the treatment of livedoid vasculopathy assessing the pain on a visual analog scale (VAS). Principal Investigator PD Dr. Tobias Grge, University Hospital of Mnster. EudraCT - Nr. 2012-000108-13.
Keywords
Versions (1)
- 11/11/15 11/11/15 -
Uploaded on
November 11, 2015
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Riliva_CRF_EudraCT - Nr. 2012-000108-13-Study termination DRKS00004652
Riliva_CRF_EudraCT - Nr. 2012-000108-13-Study termination
- StudyEvent: ODM
Similar models
Riliva_CRF_EudraCT - Nr. 2012-000108-13-Study termination
- StudyEvent: ODM
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
date
Item
Date of termination:
date
Center number
Item
Center number:
integer
Item
Reasons for study termination
text
C0008972 (UMLS CUI [1,1])
C0013135 (UMLS CUI [1,2])
C1272707 (UMLS CUI [1,3])
C0013135 (UMLS CUI [1,2])
C1272707 (UMLS CUI [1,3])
CL Item
Revocation of Consent by patient (1)
CL Item
Early ending of the entire study (2)
CL Item
Lack of patient compliance (3)
CL Item
Fall in hemoglobin of more than 2 units [g / dL] from initial value and source of bleeding can not be stopped (4)
CL Item
Decision of the investigator that further participation of the patient in the study is not justifiable (5)
CL Item
Violation of inclusion or exclusion criteria after 1st dose study medication (6)
inclusion criteria; exclusion criteria
Item
Please mention the criteria, if inclusion or exclusion criteria is the reason for study drop out.
text
C1512693 (UMLS CUI [1,1])
C0680251 (UMLS CUI [1,2])
C0680251 (UMLS CUI [1,2])